[Typhoid fever: relapse due to antimicrobial resistance. Case report].
We report for the first time in the Brazilian Amazon a typhoid fever patient with clinical and laboratorial resistance to chloramphenicol, drug of election for this disease in our region. The relapse was observed at the 7th day after the end of treatment and the patient was treated with ciprofloxacin.
Alecrim
Wilson Duarte
WD
Fundação Universidade do Amazonas, Manaus, Brasil. walecrim@uol.com.br
Loureiro
Adalgisa Câmara de Sá Peixoto
AC
Moraes
Ricardo Silva
RS
Monte
Rossicleia Lins
RL
de Lacerda
Marcus Vinícius Guimarães
MV
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002648:Child; D002701:Chloramphenicol / Q000627:therapeutic use*; D002702:Chloramphenicol Resistance; D002939:Ciprofloxacin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D012008:Recurrence; D012485:Salmonella typhi / Q000187:drug effects*; D014435:Typhoid Fever / Q000188:drug therapy*
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D002701:Chloramphenicol